Unintended pregnancy in a commercially insured population.

被引:14
|
作者
Green D.C. [1 ]
Gazmararian J.A. [1 ]
Mahoney L.D. [1 ]
Davis N.A. [1 ]
机构
[1] Department of Health Policy and Management, Emory Center on Health Outcomes and Quality, Rollins School of Public Health of Emory University, Atlanta, 30322, Georgia
关键词
pregnancy; unwanted pregnancy; contraception behavior; health services research; managed care programs;
D O I
10.1023/A:1019778129435
中图分类号
学科分类号
摘要
OBJECTIVES: While much attention has been focused on unintended pregnancy in disadvantaged populations, few studies have focused on women in lower risk groups. This study, conducted in a national managed care organization, reports the prevalence of unintended pregnancy resulting in live births and examines associated factors METHODS: Women ages 18-49 who delivered a live infant during a 6-month interval were eligible for the study. Telephone surveys were conducted after delivery. We report the rate of unintended pregnancy resulting in a live birth, and describe its association with sociodemographic and pregnancy-related factors, partner's intention status, and contraceptive use. RESULTS: Of 1173 births, 29% were unintended. Women who reported that the partner did not want the pregnancy were 7.4 times more likely than women whose partner wanted the pregnancy to regard the pregnancy as unintended. Only 40% of the women with an unintended birth used birth control and 64% of those used less effective methods such as condoms and diaphragms. CONCLUSIONS: In a population where the majority of women were married, educated, and with incomes over $40,000, almost 1/3 of the births resulted from unintended pregnancies. Future research is needed to help us better understand contradictions in pregnancy intention and contraceptive behavior. Comprehensive efforts are needed to promote consistent and correct use of contraception by women at risk for unintended pregnancy, and to involve male partners in family planning.
引用
收藏
页码:181 / 187
页数:6
相关论文
共 50 条
  • [41] Assessment of wheeled mobility devices provided to a commercially insured population in 2017
    Sprigle, Stephen
    Chen, Jie
    Hughes, Danny
    [J]. ASSISTIVE TECHNOLOGY, 2022, 34 (03) : 308 - 315
  • [42] Enrollment patterns and health in claims data for the commercially insured US population
    Teltsch, Dana Y.
    Cheever, Elizabeth
    Albright, Dawn G.
    Gierada, Monica
    Wyss, Richard
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 111 - 112
  • [43] Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population
    Funch, Donnie
    Mortimer, Kathleen
    Ziyadeh, Najat J.
    Seeger, John D.
    Li, Ling
    Norman, Heather
    Major-Pedersen, Atheline
    Bosch-Traberg, Heidrun
    Gydesen, Helge
    Dore, David D.
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (08): : 1837 - 1848
  • [44] Patient Profile and Treatment Patterns in a Commercially Insured Population with Follicular Lymphoma
    Fowler, Nathan H.
    Hao, Yanni
    Lim, Stephen
    Chen, Guifang
    Li, Frank
    Arcona, Steve
    [J]. BLOOD, 2019, 134
  • [45] Comorbidity clusters in hidradenitis suppurativa in a large commercially insured population in the US
    Hua, V. J.
    Cho, H.
    Li, S.
    Sarin, K. Y.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S46 - S46
  • [46] Use Of Oral and Subcutaneous MTX In a Commercially Insured Rheumatoid Arthritis Population
    Curtis, Jeffrey R.
    Xie, Fenglong
    Zhang, Jie
    Chen, Lang
    Yun, Huifeng
    Schiff, Michael H.
    Beukelman, Timothy
    Ginsberg, Seth
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S450 - S450
  • [47] COMBINATION UTILIZATION PATTERNS AND TREATMENT PREDICTORS IN ADHD IN A COMMERCIALLY INSURED POPULATION
    Bernauer, M.
    Farr, A.
    Haynes, V
    Montejano, L. B.
    Lenhart, G.
    Pohl, G.
    Kelsey, D.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A84 - A85
  • [48] ESTIMATES OF POSTPARTUM DEPRESSION PREVALENCE IN A COMMERCIALLY INSURED POPULATION - A RETROSPECTIVE ANALYSIS
    Bonthapally, V
    Broder, M. S.
    Tieu, R. S.
    Gannu, L.
    Meltzer-Brody, S.
    Chang, E.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A350 - A350
  • [49] PATELLA FRACTURE: COST, COMPLICATIONS AND TREATMENTS IN THE COMMERCIALLY-INSURED POPULATION
    Vanderkarr, M.
    Chitnis, A. S.
    Sparks, C.
    Holy, C. E.
    [J]. VALUE IN HEALTH, 2018, 21 : S175 - S176
  • [50] Economic burden of sarcoidosis in a commercially-insured population in the United States
    Rice, J. Bradford
    White, Alan
    Lopez, Andrea
    Conway, Alexandra
    Wagh, Aneesha
    Nelson, Winnie W.
    Philbin, Michael
    Wan, George J.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (10) : 1048 - 1055